Renal tubulopathies: genes and variants
Explore variant evidence for Renal tubulopathies across 3 analyzed proteins (SLC12A3, SLC4A1, AVPR2). Linked ClinVar records include 16 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Renal tubulopathies
SLC12A3: Solute carrier family 12 member 3
It reabsorbs sodium and chloride in the distal convoluted tubule and is a major determinant of renal salt and magnesium handling. Biallelic loss-of-function variants cause Gitelman syndrome with hypokalemic metabolic alkalosis, hypomagnesemia, and low urinary calcium.
14 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in SLC12A3 have source records linked to Renal tubulopathies. Association strength is not clinical gene validity.
SLC4A1: Band 3 anion transport protein
In red blood cells it exchanges chloride and bicarbonate to support carbon-dioxide transport, while in renal intercalated cells it is required for acid-base regulation. Pathogenic variants can cause hereditary spherocytosis or distal renal tubular acidosis depending on the affected function.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SLC4A1 have source records linked to Renal tubulopathies. Association strength is not clinical gene validity.
AVPR2: Vasopressin V2 receptor
A vasopressin receptor in kidney collecting-duct cells that activates cAMP signaling and promotes insertion of aquaporin-2 water channels. Pathogenic variants can cause X-linked nephrogenic diabetes insipidus.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in AVPR2 have source records linked to Renal tubulopathies. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ATP6V1B1.
ClinVar pathogenic and likely pathogenic variants linked to Renal tubulopathies
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC12A3 A166V | 166 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| AVPR2 R202C | 202 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| SLC12A3 L850P | 850 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC4A1 T837M | 837 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T163M | 163 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 W172R | 172 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R209Q | 209 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 C430S | 430 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G741R | 741 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R852C | 852 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R955Q | 955 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T392I | 392 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R642H | 642 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R321W | 321 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R334W | 334 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G980R | 980 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
Which prediction tools work for Renal tubulopathies
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 98 out of 100
- CADD: 95 out of 100
- REVEL: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 88 out of 100
- SIFT: 82 out of 100
- SpliceAI: 70 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Familial hypokalemia-hypomagnesemia also has ClinVar records linked to SLC12A3 variants; they fall mostly in different places as the Renal tubulopathies variants (115 pathogenic / likely pathogenic).
- Hereditary spherocytosis also has ClinVar records linked to SLC4A1 variants; they fall mostly in different places as the Renal tubulopathies variants (13 pathogenic / likely pathogenic).
- Autosomal dominant distal renal tubular acidosis also has ClinVar records linked to SLC4A1 variants; they fall mostly in different places as the Renal tubulopathies variants (11 pathogenic / likely pathogenic).
- Cryohydrocytosis also has ClinVar records linked to SLC4A1 variants; they fall mostly in different places as the Renal tubulopathies variants (9 pathogenic / likely pathogenic).
- Diabetes insipidus, nephrogenic, X-linked also has ClinVar records linked to AVPR2 variants; they fall mostly in different places as the Renal tubulopathies variants (25 pathogenic / likely pathogenic).
- Nephrogenic diabetes insipidus also has ClinVar records linked to AVPR2 variants; they fall mostly in different places as the Renal tubulopathies variants (7 pathogenic / likely pathogenic).
- Nephrogenic syndrome of inappropriate antidiuresis also has ClinVar records linked to AVPR2 variants; they fall mostly in different places as the Renal tubulopathies variants (7 pathogenic / likely pathogenic).
Diseases related to Renal tubulopathies
- Familial hypokalemia-hypomagnesemia, also linked to SLC12A3
- Nephrotic syndrome, also linked to SLC12A3
- Bartter syndrome, also linked to SLC12A3
- Nephrogenic diabetes insipidus, also linked to AVPR2
- Diabetes insipidus, nephrogenic, X-linked, also linked to AVPR2
- Hereditary spherocytosis, also linked to SLC4A1
- Autosomal dominant polycystic kidney disease, also linked to AVPR2
- Autosomal dominant distal renal tubular acidosis, also linked to SLC4A1
- Cryohydrocytosis, also linked to SLC4A1
- Nephrogenic syndrome of inappropriate antidiuresis, also linked to AVPR2
- Myocardial infarction, also linked to SLC12A3
- Southeast Asian ovalocytosis, also linked to SLC4A1
Frequently asked questions
Which genes have records linked to Renal tubulopathies?
This view contains 3 analyzed proteins: SLC12A3, SLC4A1, AVPR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 16 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 24 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center